The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson’s disease

BACKGROUND: The PD COMM trial is a phase III multi-centre randomised controlled trial whose aim is to evaluate the effectiveness and cost-effectiveness of two approaches to speech and language therapy (SLT) compared with no SLT intervention (control) for people with Parkinson’s disease who have self...

Descripción completa

Detalles Bibliográficos
Autores principales: Masterson-Algar, Patricia, Burton, Christopher R., Brady, Marian C., Nicoll, Avril, Clarke, Carl E., Rick, Caroline, Hughes, Max, Au, Pui, Smith, Christina H., Sackley, Catherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576370/
https://www.ncbi.nlm.nih.gov/pubmed/28851443
http://dx.doi.org/10.1186/s13063-017-2130-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576370/
https://www.ncbi.nlm.nih.gov/pubmed/28851443
http://dx.doi.org/10.1186/s13063-017-2130-1

Ejemplares similares